Secondary infections in COVID-19: Antemortem and postmortem culture study
Indian Journal of Pathology and Microbiology · 2023
DOI: 10.4103/ijpm.ijpm_141_22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2023. Verfasst von Vandana V Kiro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Division of Forensic Pathology and Molecular DNA, New Delhi, India. Hauptthemen laut MEDLINE: Coinfection, COVID-19, Bacterial Infections. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Secondary bacterial infections during COVID-19 hospitalization have been reported in about 6–15% of patients.
Aims
To study the secondary bacterial infections that affected the COVID-19 patients during their hospitalisation and to unearth the bacteriological profile of samples obtained after their demise. Settings and Design: This prospective study was carried out at a COVID-19 dedicated, apex tertiary care centre in North India from July 2020 to April 2021. Methods and Material: Samples of 268 patients were considered for the study. Nasopharyngeal swab specimen, blood, and tissue (lung) were collected from the deceased body as early as possible and processed. Statistical Analysis: Statistical analyses were performed using STATA version 11.1 (Stata Corp., College Station, TX, USA).
Results
A total of 170 samples were received from patients before their death, which included blood, urine, respiratory samples, pus, and cerebrospinal fluid. Forty-four pathogens were isolated, which consisted of Acinetobacter baumannii (43.1%), Klebsiella pneumoniae (36.3%), Escherichia coli (11.3%), and Pseudomonas aeruginosa (4.5%), Enterococcus faecium (4.5%). Two hundred fifty-eight samples were collected from the deceased bodies wherein the nasopharyngeal sample was highest, followed by tissue and blood. A total of 43 pathogens were isolated among them which included A. baumannii (44.1%), followed by K. pneumoniae (25.5%), E. coli (20.9%), P. aeruginosa (6.97%) and Enterobacter cloacae (2.3%). All these isolates were highly resistant to antimicrobials.
Conclusions
In our study, bacterial profiles in antemortem and postmortem samples were found to be similar, suggesting that resistant pathogens may be the cause of mortality in COVID-19 infected hospitalised patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Division of Forensic Pathology and Molecular DNA, New Delhi, India.
- PhD Scholar, Division of Forensic Pathology and Molecular DNA, New Delhi, India.
- Division of Clinical Microbiology, Department of Laboratory Medicine, JPNATC, All India Institute of Medical Sciences, New Delhi, India.
- Department of Anaesthesia and Critical Care, All India Institute of Medical Sciences, New Delhi, India.
- Department of Orthopedics, All India Institute of Medical Sciences, New Delhi, India.
- Division of Forensic Pathology and Molecular DNA, JPNATC, New Delhi, India.
Zitieren
APA
Kiro, V. V., Sharma, M., Srivastava, S., Lalwani, P., Aggarwal, R., Soni, K. D., Malhotra, R., Lalwani, S., Mathur, P., & Trikha, A. (2023). Secondary infections in COVID-19: Antemortem and postmortem culture study. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_141_22
Vancouver
Kiro VV, Sharma M, Srivastava S, Lalwani P, Aggarwal R, Soni KD, et al. Secondary infections in COVID-19: Antemortem and postmortem culture study. Indian Journal of Pathology and Microbiology. 2023. doi:10.4103/ijpm.ijpm_141_22
BibTeX
@article{Kiro2023,
author = {Kiro, Vandana V and Sharma, Meenakshi and Srivastava, Sharad and Lalwani, Parin and Aggarwal, Richa and Soni, Kapil D and Malhotra, Rajesh and Lalwani, Sanjeev and Mathur, Purva and Trikha, Anjan},
title = {Secondary infections in COVID-19: Antemortem and postmortem culture study},
journal = {Indian Journal of Pathology and Microbiology},
year = {2023},
doi = {10.4103/ijpm.ijpm_141_22}
}
EUVIMED